All Articles

A new Kickstarter promises a full-size arcade that folds into a stylish cabinet, blending retro nostalgia with modern living and console compatibility.

Online sellers in coaching and supplements face account freezes. A new service says prevention is key, offering stable processing for at-risk businesses.

Pharma and COVID-response leader John Young joins UCSF's QBI to translate its cutting-edge protein science into transformative therapies and partnerships.

A new partnership embeds payments directly into payroll, promising a unified, end-to-end solution for multinational companies and closing a critical industry gap.

Terrestrial Energy's molten salt reactor clears a major regulatory hurdle, a critical step toward decarbonizing heavy industry and powering the digital economy.

ODAIA's new AI platform moves beyond static segments to treat each doctor as a 'segment of one,' promising to boost engagement and slash marketing waste.

A new 'agentic storefront' is promising 2x conversion rates by giving brands their own AI, challenging the model of ceding customer data to big tech.

Risk management leader Crisis24 hits AWS Marketplace, letting firms use committed cloud spend for its AI-powered security and intelligence platform.

Response Pharmaceuticals unveils promising data on RDX-002, a first-in-class drug aimed at preventing a severe side effect of essential mental health drugs.

A new virtual forum offers a confidential, no-fee space for rising family office leaders, addressing a critical gap in leadership development and stewardship.

From lab breakthroughs to Hollywood advocacy, the 2026 Reeve Summit showcases a powerful, multi-front strategy to cure paralysis and enrich lives today.

S2G Investments launches a $1B fund to scale growth-stage firms in food, energy, and oceans, bridging a critical financing gap for market-ready solutions.

Arvinas secures a historic first FDA approval for a PROTAC drug and inks a deal to fuel a deep pipeline targeting cancer and neurodegenerative diseases.

As data breach litigation skyrockets, specialist law firm Mullen Coughlin bolsters its defense with the strategic hire of 30-year trial veteran MaryEllen Conroy.

Facing delisting, Solana infrastructure firm Solmate executes a reverse split. Is it a strategic reset for its UAE ambitions or a sign of deeper trouble?

A Belgian firm's new biologic gel for diabetic foot ulcers gets a key FDA green light, offering hope against a leading cause of amputations.

Amidst a quarterly loss, Coincheck inks a major deal with telco giant KDDI and expands into institutional ETFs, betting big on a diversified future.

New platform VibeFlow promises to bring AI coding speed to regulated industries by deploying AI agent teams that maintain compliance and auditability.

Impulse Biomedical, a Cape Town startup, enters the US market via a Maryland program, bringing a reloadable epi-pen and an ergonomic inhaler sleeve.

A new report reveals widespread 'relaxation guilt' is fueling a burnout crisis. Many are now ditching long trips for short 'daycations' to find relief.